Jorda, Anselm
Hengstenberg, Christian
Lang, Irene M.
Kautzky-Willer, Alexandra
Harreiter, Jürgen
Zeitlinger, Markus
Jilma, Bernd
Gelbenegger, Georg
Clinical trials referenced in this document:
Documents that mention this clinical trial
Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial
https://doi.org/10.1161/circinterventions.121.010925
Stable coronary artery disease: revascularisation and invasive strategies
https://doi.org/10.1016/s0140-6736(15)61220-x
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention
https://doi.org/10.1016/j.ahj.2012.05.018
Percutaneous recanalization of chronic total occlusions: Wherein lies the body of proof?
https://doi.org/10.1016/j.ahj.2012.10.017
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA
https://doi.org/10.1161/circulationaha.121.057363
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
https://doi.org/10.1161/circinterventions.123.013435
Assessment of patients with stable chest pain
https://doi.org/10.1136/heartjnl-2017-311212
Application of speCtraL computed tomogrAphy to impRove specIficity of cardiac compuTed tomographY (CLARITY study): rationale and design
https://doi.org/10.1136/bmjopen-2018-025793
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial
https://doi.org/10.1161/circinterventions.123.013743
Cardiovascular health technology assessment: recommendations to improve the quality of evidence
https://doi.org/10.1136/openhrt-2018-000930
Outcomes of Participants With Diabetes in the ISCHEMIA Trials
https://doi.org/10.1161/circulationaha.121.054439
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity
https://doi.org/10.1161/circulationaha.120.049755
PCI does not improve outcomes for patients with stable angina
https://doi.org/10.1136/bmjebm-2018-110903
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction
https://doi.org/10.1161/circulationaha.120.050304
Percutaneous coronary intervention for stable coronary artery disease
https://doi.org/10.1136/heartjnl-2017-312755
Myocardial Infarction in the ISCHEMIA Trial
https://doi.org/10.1161/circulationaha.120.047987
Meta-Analysis of Trials on Mortality After Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Stable Coronary Heart Disease and Objective Evidence of Myocardial Ischemia
https://doi.org/10.1016/j.amjcard.2015.01.556
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial
https://doi.org/10.1161/circoutcomes.123.010534
Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA
https://doi.org/10.1161/circulationaha.123.066980
What role for PCI in stable ischaemic heart disease?
https://doi.org/10.1136/dtb.2021.000040
Validation of the SYNTAX Revascularization Index to Quantify Reasonable Level of Incomplete Revascularization After Percutaneous Coronary Intervention
https://doi.org/10.1016/j.amjcard.2015.03.056
Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials
https://doi.org/10.1186/s12933-024-02232-z
Article History
Received: 6 March 2024
Accepted: 10 April 2024
First Online: 20 May 2024
Declarations
:
: The trials were approved by the NYU School of Medicine Institutional Review Board. The Ethics committee of the Medical University of Vienna waived the need for review.
: Not applicable.
: None of the authors report conflict of interests relevant to this work.